Vectron Biosolutions AS is your expert on developing cost-effective microbial production processes for recombinant proteins

Do you need to cut manufacturing costs?

The manufacturing costs of many recombinant proteins can be significantly reduced through increasing titres and improving the solubility of the proteins, reducing the necessities of costly downstream processes. This is increasingly important in the competitive landscape of the biopharmaceutical industry, especially with the advent of biosimilars and biobetters, as well as for suppliers of industrial enzymes where the markets are smaller.

Vectron Biosolutions is your upstream expert on developing robust, cost-efficient production processes for recombinant proteins in E. coli and other bacteria. We have proprietary next-generation expression tools and decades of experience that is available to you through partnerships and licensing.

Latest news

  • New scientific paper

    June 22 | 2020

    We have recently co-authored a great new paper on translocation.

    Read more
  • Vectron is granted new patent

    August 04 | 2019

    Vectron's dual UTR technology has now been granted patent protection by the European Patent Office.

    Read more
  • Vectron enters collaboration with Mycenax Biotech Inc.

    May 29 | 2019

    Vectron and Mycenax will collaborate to offer a complete and superior solution for microbial production of therapeutic proteins.

    Read more
  • Vectron Biosolutions participated on this year's VIVO career day at NTNU

    February 06 | 2019

    Read more
Complete newslist


Meet us there!
More events